Spatial Omics Frontiers | Revealing Functional Tissue Architecture with AI-Driven Multiomics
Join us for an engaging webinar where we explore the groundbreaking integration of spatial transcriptomics and proteomics through AI-driven analytics.
Join us for an engaging webinar where we explore the groundbreaking integration of spatial transcriptomics and proteomics through AI-driven analytics.
In this webinar, Dr. Suzuki will share the latest advancements in spatial analytical platforms that illuminate the micro-heterogeneity of lung adenocarcinoma.
Join this inaugural session of the Spatial Omics Frontiers series as Niro Ramchandran PhD, Chief Business Officer, Akoya Biosciences explores how the combination…
Join this webinar to hear Dr. Inês Sequeira describe how multi-omic spatial technologies have been used to build the first Oral Cell Atlas, for…
A Single-Cell and Spatially-Resolved Atlas of the Human and Murine Oral Cavity Read More »
Join us to learn how recent discoveries about the brain tumor microenvironment can drive new therapeutic strategies to overcome tumor immunosuppression.
Reprogramming the BrainTumor Microenvironment to Enhance Anti-Tumor Immunity Read More »
In this webinar, learn how single-cell multiomic spatial phenotyping is an invaluable tool to characterize the tumor microenvironment using unbiased whole-slide imaging of metastatic/recurrent…
Spatial Omics for Targeted Cancer Immunotherapies Read More »
Spatial phenotyping enables whole-slide imaging at single-cell resolution, revealing cellular interactions and quantifying biomarkers while maintaining detail. This revolutionizes research in oncology, immunology, and…
The Power of Spatial Phenotyping: From Discoveries to Actionable Spatial Signatures Read More »
In this webinar, Dr. Quan Nguyen and Dr. Jazmina Gonzalez Cruz introduce the study on spatial map for skin cancer, COVID infected lung tissues…
Exploring Spatial Omics: From Laboratory Research to Oncology Practice Read More »
In this webinar, Dr. Victor Arrieta highlights the link between p-ERK activation and improved survival in rGBM patients using anti-PD-1 immunotherapy.
Join us for an in-depth exploration led by Senior Field Applications Scientist, Antoinette Ronquillo, as she unveils the groundbreaking advancements driving PhenoCycler-Fusion 2.0 to…